ViroPharma Announces Extension of Hepatitis C Screening Phase of Collaboration with Wyeth
June 19, 2002 08:00 ET
|
ViroPharma Incorporated
EXTON, Pa., June 19, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has extended the screening phase of its HCV drug discovery, development and commercialization...
Notice: ViroPharma Incorporated Teleconference Call
June 05, 2002 07:00 ET
|
ViroPharma Incorporated
EXTON, Pa., June 5, 2002 (PRIMEZONE) -- ViroPharma (Nasdaq:VPHM) will hold a teleconference call today, Wednesday, June 5, 10:30 a.m. (EST) to provide a further update on the Picovir(tm) NDA.
To...
ViroPharma Provides Further Update on Picovir� NDA
June 04, 2002 21:00 ET
|
ViroPharma Incorporated
EXTON, Pa., June 4, 2002 (PRIMEZONE) -- As the Company expected and had previously announced, ViroPharma Incorporated (Nasdaq:VPHM) recently received a "not approvable" letter from the U.S. Food and...
ViroPharma and Aventis Provide Update on Picovir� NDA
May 09, 2002 18:19 ET
|
ViroPharma Incorporated
EXTON, Pa. and BRIDGEWATER, N.J., May 9, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) recently met with officials from the U.S. Food and Drug Administration to discuss ViroPharma's new...
ViroPharma Incorporated Reports First Quarter Financial Results
May 01, 2002 08:00 ET
|
ViroPharma Incorporated
EXTON, Pa., May 1, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today reported financial results for the first quarter ended March 31, 2002.
For the quarter ended March 31, 2002,...
Notice: ViroPharma Incorporated Teleconference Call
March 19, 2002 21:15 ET
|
ViroPharma Incorporated
EXTON, Pa., March 19, 2002 (PRIMEZONE) -- ViroPharma (Nasdaq:VPHM) will hold a teleconference call Wednesday, March 20 10:30 a.m. (EST) to discuss the results of the FDA Advisory Committee meeting...
PICOVIR - pleconaril - Reviewed by FDA Advisory Committee
March 19, 2002 20:31 ET
|
ViroPharma Incorporated
GAITHERSBURG, Md., March 19, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) and Aventis Pharmaceuticals (NYSE:AVE), the U.S. pharmaceutical business of Aventis Pharma AG, announced today...
Picovir -- pleconaril -- to be Reviewed by FDA Antiviral Drugs Advisory Committee on March 19, 2002
February 06, 2002 04:00 ET
|
ViroPharma Incorporated
EXTON, Pa. and BRIDGEWATER, N.J., Feb. 6, 2002 -- ViroPharma Incorporated (Nasdaq:VPHM) and Aventis Pharmaceuticals, the U.S. pharmaceutical company of Aventis Pharma AG, today announced that the new...